HIV AIDS Immune System Quiz: Viral Pathogenesis

If a virus carries its genetic information as RNA and must convert it into DNA inside a host cell, then it is a retrovirus; if HIV uses this specific reverse process, then it belongs to the retrovirus family.

If HIV is the virus that causes an infection, then it is the causative agent; if AIDS is the late stage of that infection characterized by severe immune failure, then they are distinct stages of a progression rather than the same condition.

If HIV targets helper T cells to disrupt the immune response, then it must find a specific docking site on those cells; if the CD4 protein is the primary receptor on helper T cells, then HIV uses CD4 to gain entry.

HIV, a retrovirus, relies on reverse transcriptase to convert its single-stranded RNA genome into double-stranded DNA. This process is crucial for the virus to integrate its genetic material into the host's DNA, allowing it to replicate and produce new viral particles. Reverse transcriptase is unique to retroviruses, enabling them to reverse the normal flow of genetic information, which typically goes from DNA to RNA. This enzyme's activity is a key target for antiretroviral therapies aimed at treating HIV infections.

If HIV exists in high concentrations in specific fluids, then contact with those fluids can spread the virus; if blood, semen, and breast milk contain high viral loads but saliva does not, then only the first four are transmission routes.

If the condition is not genetic but 'acquired' via a virus, and it results in a 'deficiency' of the 'immune' system through a 'syndrome' of symptoms, then the term is acquired immunodeficiency syndrome.

If HIV destroys the helper T cells that coordinate defenses, then the body cannot fight common germs; if these 'opportunistic' germs cause fatal illness because the immune system is failed, then they are the leading cause of death in AIDS patients.

Antiretroviral therapy (ART) is a crucial treatment for individuals living with HIV. It involves a combination of medications that target different stages of the HIV life cycle, effectively reducing the virus's replication in the body. By maintaining low viral loads, ART helps preserve the immune system, preventing the progression of HIV to AIDS. Regular adherence to this therapy not only improves the health and longevity of those infected but also significantly reduces the risk of transmitting the virus to others.

If the immune system is partially controlling the virus, then symptoms may disappear for years; if the virus is still slowly destroying T cells during this time, then the stage is described as a period of clinical latency.

If a doctor needs to verify infection, then they look for antibodies or viral RNA; if they need to monitor the health of the system, they check T cell counts. If x-rays only show structural damage and not the virus itself, then only the first four are direct monitoring tools.

If the virus uses the enzyme integrase, then it can splice its viral DNA into the host's chromosome; if this happens, then the virus becomes a permanent part of the host's genetic code, making the statement true.

gp120 is a glycoprotein found on the surface of the HIV virus that specifically binds to the CD4 receptor on T cells. This interaction is crucial for the virus's entry into the host cell, as it facilitates the fusion of the viral envelope with the cell membrane. By attaching to CD4, gp120 also induces conformational changes that allow the virus to interact with co-receptors, further enabling the infection process. Thus, gp120 plays a vital role in the mechanism by which HIV infects T cells, leading to immune system compromise.

If the virus replicates quickly with many errors (mutations), then its surface 'look' changes constantly; if it also hides as a 'provirus' in host DNA, then the immune system cannot find or recognize it effectively.

If the immune system is considered 'failed' when a specific threshold of helper cells is lost, then a numerical limit must be set; if 200 cells per mm^3 is the established medical threshold for AIDS, then answer a is the diagnostic trigger.

If medication (ART) stops the virus from replicating to the point that it cannot be detected in blood tests, then there is very little virus to pass on; if 'undetectable = untransmittable' (U=U), then the statement is true.

When viral DNA integrates into the host's genome, it becomes a provirus. This term refers to the viral genetic material that is incorporated into the host's DNA, allowing the virus to replicate along with the host's cellular division. The provirus can remain dormant or be activated to produce new viral particles, contributing to the virus's lifecycle and persistence within the host organism. This mechanism is common in certain viruses, such as retroviruses, which utilize reverse transcription to integrate their genetic material into the host's genome.

If an illness only becomes a major threat when the immune system is severely compromised, then it defines the transition to AIDS; if Kaposi's sarcoma and specific pneumonias are rare in healthy people but common in AIDS, then they are AIDS-defining. The common cold happens to everyone.

If helper T cells are the 'generals' that release cytokines to activate other units, then their destruction removes the signal to fight; if no signals are sent to B cells or killer T cells, then the entire adaptive defense fails, as explained in our HIV AIDS immune system quiz.

If the virus produces its proteins in one long, useless strand, then it needs a 'scissors' to make them work; if the protease enzyme performs this cutting during the final assembly of new viruses, then the statement is true.

If HIV is transmitted through specific body fluids during high-risk activities, then prevention must block those fluids or provide a chemical shield; if condoms act as a barrier and PrEP acts as a chemical shield, then they are the most effective prevention methods.